Centiva Capital »

Ocular Therapeutix shares owned by Centiva Capital

Quarter-by-quarter ownership of Ocular Therapeutix (OCUL) shares owned by Centiva Capital from 13F filings

Historical chart of Centiva Capital investment in Ocular Therapeutix

Tip: Access up to 7 years of quarterly data

All positions including Ocular Therapeutix held by Centiva Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ocular Therapeutix by Centiva Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $3.2M 273k 11.69
2024-03-31 $565k 62k 9.10

More positions owned by Centiva Capital

Ishares Tr Russell 2000 Etf (IWM)
NVIDIA Corporation (NVDA)
Ishares Tr Iboxx Hi Yd Etf Call Option (HYG)
Alibaba Group Hldg Sponsored Ads Call Option (BABA)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Tesla Motors (TSLA)
Regeneron Pharmaceuticals Call Option (REGN)
Pdd Holdings Sponsored Ads (PDD)
Microsoft Corporation (MSFT)
Eli Lilly & Co. (LLY)
Meta Platforms Cl A (META)
Amazon (AMZN)
Kraneshares Trust Csi Chi Internet Put Option (KWEB)
Apple Call Option (AAPL)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)

View all positions for Centiva Capital

Top funds holding Ocular Therapeutix

FMR
VR Adviser
Summer Road
Deep Track Capital
BlackRock
venBio Select Advisor
Vanguard Group
TCG Crossover Management
Citadel Advisors
Point72 Asset Management
Adage Capital Partners GP
Millennium Management
Paradigm Biocapital Advisors
State Street Corporation
Alliancebernstein

View all funds holding Ocular Therapeutix